These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6351341)

  • 21. [The role of prostaglandins in platelet aggregation in metabolic syndrome].
    Sokolov EI; Lavrenova NIu; Goloborodova IV
    Vestn Ross Akad Med Nauk; 2010; (4):22-6. PubMed ID: 20540350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy.
    Schernthaner G; Sinzinger H; Silberbauer K; Freyler H; Mühlhauser I; Kaliman J
    Horm Metab Res Suppl; 1981; 11():33-43. PubMed ID: 6459282
    [No Abstract]   [Full Text] [Related]  

  • 23. Lack of interaction of heparin with ADP and prostacyclin on rat platelets.
    Roncaglioni MC; Bertelé V; de Gaetano G; Donati MB
    Thromb Res; 1983 Jul; 31(2):397-400. PubMed ID: 6356460
    [No Abstract]   [Full Text] [Related]  

  • 24. Prostaglandins and platelet function.
    Salzman EW
    Adv Prostaglandin Thromboxane Res; 1976; 2():767-80. PubMed ID: 185888
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J; Parkinson S; Timmons S
    Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with transfusion of leukocyte-poor platelet concentrates prepared by filtration with prostacyclin.
    van Prooijen HC; Riemens TI; Akkerman JW
    Blood; 1987 Jul; 70(1):243-6. PubMed ID: 3297202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
    Onodera H; Hirata T; Sugawara H; Sugai K; Yoda B; Toyota T; Goto Y
    Tohoku J Exp Med; 1982 Aug; 137(4):423-8. PubMed ID: 6750843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human platelet activation by an alkylacetyl analogue of phosphatidylcholine.
    Rao GH; Schmid HH; Reddy KR; White JG
    Biochim Biophys Acta; 1982 Apr; 715(2):205-14. PubMed ID: 6280777
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
    J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet alterations in shear flow: dose response of prostacyclin on human platelets.
    Hung TC; Butter DB; Graham MF; Lewis JH; Zhao JQ; Haubold AD
    Trans Am Soc Artif Intern Organs; 1983; 29():436-41. PubMed ID: 6424310
    [No Abstract]   [Full Text] [Related]  

  • 31. Ingestion of dipyridamole reduces inhibitory effect of prostacyclin on human platelets.
    Di Minno G; Silver MJ; De Gaetano G
    Lancet; 1979 Sep; 2(8144):701-2. PubMed ID: 90798
    [No Abstract]   [Full Text] [Related]  

  • 32. Heparin neutralization of PGI2: effects upon platelets.
    Saba HI; Saba SR; Blackburn CA; Hartmann RC; Mason RG
    Science; 1979 Aug; 205(4405):499-501. PubMed ID: 377493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and washing of human platelets with nitric oxide.
    Radomski MW; Palmer RM; Read NG; Moncada S
    Thromb Res; 1988 May; 50(4):537-46. PubMed ID: 2842884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
    Maurin N
    Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for the mechanism by which eicosapentaenoic acid inhibits human platelet aggregation and secretion - implications for the prevention of vascular disease.
    Jakubowski JA; Ardlie NG
    Thromb Res; 1979; 16(1-2):205-17. PubMed ID: 388720
    [No Abstract]   [Full Text] [Related]  

  • 37. Mode of action of dipyridamole on human platelets.
    Best LC; McGuire MB; Jones PB; Holland TK; Martin TJ; Preston FE; Segal DS; Russell RG
    Thromb Res; 1979; 16(3-4):367-79. PubMed ID: 229583
    [No Abstract]   [Full Text] [Related]  

  • 38. Epinephrine induces Ca2+ uptake in human blood platelets.
    Owen NE; Feinberg H; Le Breton GC
    Am J Physiol; 1980 Oct; 239(4):H483-H488. PubMed ID: 7425140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release of a prostacyclin-like substance into the circulation of dogs by intravenous adenosine 5'-diphosphate.
    Hemker DP; Shebuski RJ; Aiken JW
    J Pharmacol Exp Ther; 1980 Feb; 212(2):246-52. PubMed ID: 6985960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.